Solid Biosciences Inc. — Director's Dealing 2020

Jul 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-07-27

Reporting Person: Ganot Ilan (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-27	Common Stock	M	35500	—	Acquired	1159131	Direct
2020-07-28	Common Stock	S	11124	$2.4191	Disposed	1148007	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-27	Restricted Stock Units	$	M	35500	Disposed		Common Stock (35500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	290914	Indirect
Common Stock	2937	Indirect

Footnotes

F1: Restricted Stock units convert into common stock on a one-for-one basis.

F2: Represents 1,098,500 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F3: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

F4: Represents 1,087,376 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F5: Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F6: On January 27, 2020, the reporting person was granted 71,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.